Gyre TherapeuticsGYRE
那斯達克 · USD
7.12
-0.11
(-1.52%)
收盤 04/03 03:59 (UTC+8)
04/03 03:59 (UTC+8)
Gyre TherapeuticsGYRE
7.12
-0.11
(-1.52%)
財務數據
損益表
- -
- 0.27
- 0.27
- 0.25
- 0.25
- 0.28
- 0.22
- 0.27
- 0.31
- 0.37
- -
- -
- -76.05
- -7.17
- 1.04
- 9.35
- -20.86
- 21.37
- 14.17
- 21.70
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 37,195 | 30,564 | 26,771 | 22,058 | 27,872 | 25,488 | 25,225 | 27,172 | 27,148 | - |
營業成本 | 1,743 | 1,628 | 1,151 | 894 | 1,177 | 958 | 770 | 979 | 1,250 | - |
營業毛利 | 35,452 | 28,936 | 25,620 | 21,164 | 26,695 | 24,530 | 24,455 | 26,193 | 25,898 | - |
營業費用 | 35,332 | 22,010 | 23,448 | 18,891 | 26,032 | 20,297 | 21,193 | 18,122 | 114,191 | 1,623 |
研發費用 | 4,815 | 2,363 | 3,425 | 3,095 | 3,712 | 2,775 | 3,355 | 2,182 | 4,568 | 415 |
推銷及管理費用 | 30,517 | 19,647 | 20,023 | 15,796 | 22,320 | 17,522 | 17,838 | 15,940 | 26,519 | 1,208 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 83,104 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 118 | 6,925 | 2,171 | 2,273 | 665 | 4,233 | 3,262 | 8,071 | -91,632 | -1,623 |
其他收入及費用 | -186 | 703 | 66 | 2,362 | 109 | -303 | 2,773 | 4,410 | -11,985 | 47 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -66 | 7,629 | 2,238 | 4,635 | 772 | 3,930 | 6,035 | 12,481 | -100,278 | -1,576 |
所得稅 | 1,300 | 1,693 | 662 | 901 | 203 | 1,074 | 1,497 | 2,546 | 699 | - |
稅後純益 | -1,723 | 3,610 | 442 | 2,698 | -99 | 1,124 | 3,528 | 7,532 | -101,006 | -1,576 |
基本每股稅後盈餘(元) | -0.02 | 0.04 | 0.00 | 0.03 | 0.00 | 0.01 | 0.04 | 0.09 | - | 0.05 |
稀釋每股稅後盈餘(元) | -0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | -1.51 | 0.05 |
基本平均股數(千股) | 91156.00 | 90850.00 | 89119.00 | 86420.00 | 85952.00 | 85643.00 | 85502.00 | 83265.00 | - | 76583.00 |
稀釋平均股數(千股) | 91156.00 | 103971.00 | 102701.00 | 101970.00 | 85952.00 | 102640.00 | 104325.00 | 102594.00 | - | 76583.00 |
還原基本每股稅後盈餘(元) | -0.02 | 0.04 | 0.00 | 0.03 | 0.00 | 0.01 | 0.04 | 0.09 | - | 0.05 |
還原稀釋每股稅後盈餘(元) | -0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | -1.51 | 0.05 |
還原基本平均股數(千股) | 91,156 | 90,850 | 89,119 | 86,420 | 85,952 | 85,643 | 85,502 | 83,265 | - | 76,583 |
還原稀釋平均股數(千股) | 91,156 | 103,971 | 102,701 | 101,970 | 85,952 | 102,640 | 104,325 | 102,594 | - | 76,583 |
EBITDA(千元) | 272 | 5,952 | 1,745 | 4,134 | 604 | 2,652 | 5,273 | 10,503 | -99,999 | -1,576 |